FolioLanternBeta
VRTXVertex Pharmaceuticals

Carmen Bozic

EVP and CMO at Vertex Pharmaceuticals, as of Jun 30, 2026Sold $11.3M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
15K
shares held after the latest filing, Vertex Pharmaceuticals
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
25K
shares sold, past 12 months
10
days with sales
$3.1M
largest single day, May 12, 2026
1
company filed for

Share of stake sold at Vertex Pharmaceuticals is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFeb 2026: $1.1M under a disclosed planFebMar 2026: $2.2M under a disclosed planMarAprMay 2026: $4.6M under a disclosed plan$4.6MMayJun 2026: $3.4M under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Vertex Pharmaceuticals (VRTX)EVP and CMOOct 3, 2019Jun 30, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.